Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion type Assertion NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_head.
- NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion wasGeneratedBy ECO_0000203 NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_provenance.
- NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion wasDerivedFrom befree-20150227 NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_provenance.
- NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion SIO_000772 23932550 NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_provenance.
- NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion evidence source_evidence_literature NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_provenance.
- NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_assertion description "[Whether PCSK9 mAbs decrease the rates of recurrent cardiovascular events within 3 months following ACS is questionable; however, these agents, unlike statins, may not have pleiotropic benefits on the unstable plaque.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981899.RA7JYJ4VQI7J-07hS0bH_yEckBm51B2PAd_ukl73oH00M130_provenance.